Bioventix appoints Bruce Hiscox as chief financial officer
Bioventix
4,450.00p
17:15 28/03/24
0.00%
0.00p
Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.
FTSE AIM 100
3,604.12
16:44 28/03/24
n/a
n/a
FTSE AIM All-Share
743.26
16:50 28/03/24
n/a
n/a
Pharmaceuticals & Biotechnology
21,366.25
17:14 28/03/24
-0.23%
-48.29
Hiscock, previously chief executive and CFO of everyLIFE Technologies, a technology business delivering digital care planning solutions to social care providers, will start in the role with immediate effect.
The AIM-listed group highlighted that Hiscock had held several CFO roles at both fast-growing listed and private companies over his 30-year career and was a member of the Institute of Chartered Accountants of Scotland.
As of 0940 BST, Bioventix shares were up 1.20% at 4,200p.